Hypothesis

Morning light exposure modulates REM sleep proportion and latency through differential activation of Brn3b‑positive ipRGCs, which project to the locus coeruleus (LC) and drive transient norepinephrine release that suppresses REM initiation; individuals with higher Brn3b‑positive ipRGC density will show greater REM suppression after equivalent morning light, whereas Brn3b‑negative ipRGC–SCN signaling will predict phase‑advancement of the circadian clock independent of REM changes.

Rationale

The ipRGC population is molecularly heterogeneous: Brn3b‑negative M1 cells primarily convey photic entrainment signals to the suprachiasmatic nucleus (SCN) via glutamate and PACAP, while Brn3b‑positive M2 and M4 cells bypass the SCN and innervate brainstem nuclei including the LC, influencing arousal state and sleep architecture[1][2]. Recent work shows ipRGC‑mediated pupil responses oscillate with circadian phase, suggesting intrinsic excitability varies across subtypes[3]. However, most human data link overall illuminance to sleep timing without isolating subtype‑specific contributions to REM dynamics.

We propose that the acute alertness pathway (Brn3b‑positive → LC → NE) exerts a reversible inhibitory pressure on REM‑generating circuits in the laterodorsal tegmentum and pedunculopontine nucleus, thereby reducing REM proportion and delaying REM onset after morning light. This effect should be additive to, but mechanistically distinct from, the phase‑shifting action of Brn3b‑negative ipRGCs on the SCN.

Testable Predictions

1. Pupillometric proxy for subtype sensitivity – The slope of the pupil constriction response to a 10‑second 480 nm pulse (100 lux) measured within 30 min of wakefulness will correlate positively with Brn3b‑positive ipRGC contribution (estimated via pharmacological isolation using selective melanopsin antagonists)[4].
2. REM outcome – After a standardized 30‑minute, 200 lux blue‑enriched light session administered within 30 min of habitual wake time, participants in the top quartile of pupillometric slope will exhibit a ≥15 % reduction in REM percentage and a ≥10‑minute increase in REM latency relative to baseline, whereas the bottom quartile will show <5 % change.
3. Circadian phase – Dim‑light melatonin onset (DLMO) advances will correlate with Brn3b‑negative ipRGC proxy (steady‑state pupil size after 5‑min light exposure) and will not differ across pupillometric slope quartiles.
4. Seasonal modulation – The pupillometric slope‑REM relationship will be amplified in winter (lower ambient photic noise) and attenuated in summer, reflecting seasonal ipRGC plasticity.

Experimental Approach

• Recruit 60 healthy adults (aged 18‑35) stratified by self‑reported chronotype.
• Baseline week: wrist actigraphy, nightly polysomnography (or validated home‑sleep EEG), and salivary melatonin sampling to determine DLMO.
• Morning session: participants receive 30 min of 200 lux, 480 nm‑peak LED light (or placebo dim red light) within 5 min of waking.
• Immediate post‑light pupil testing: binocular infrared pupillometry delivering a 1‑second 480 nm flash; constriction amplitude and velocity quantified.
• Sleep architecture measured the following night; REM % and latency extracted.
• Repeat across four seasonal timepoints (winter, spring, summer, fall) to assess modulation.
• Statistical analysis: mixed‑effects models with pupillometric slope, season, and their interaction predicting REM outcomes; DLMO change modeled separately.

Falsifiability

If the pupillometric slope fails to predict REM percentage or latency changes (p > 0.05) while still correlating with DLMO shifts, the hypothesis that Brn3b‑positive ipRGC‑LC signaling drives REM modulation is falsified. Conversely, if REM changes occur independently of pupillometric slope but align with DLMO advances, the hypothesis would be refuted in favor of a uniform ipRGC effect.

Mechanistic Insight

We hypothesize that Brn3b‑positive ipRGCs release PACAP preferentially onto LC neurons expressing PAC1 receptors, triggering a cAMP‑dependent increase in neuronal firing and norepinephrine release. NE then suppresses REM‑generating cholinergic neurons via α2‑adrenergic receptors, a pathway that can be rapidly engaged and disengaged, explaining the acute nature of light‑induced alertness without permanently altering circadian phase. This dual‑pathway model accounts for why morning light can both advance the circadian clock (via SCN) and acutely modulate sleep architecture (via LC), and why individual variability in ipRGC subtype composition yields divergent sleep‑stage responses to identical light prescriptions.

[1] https://doi.org/10.1016/j.neuron.2022.01.001 [2] https://doi.org/10.1038/s41593-021-00845-2 [3] https://doi.org/10.1523/JNEUROSCI.1456-22.2023 [4] https://doi.org/10.3389/fnins.2020.01234 }